The State of AI in Healthcare RCM: Key Trends, Insights, and Strategies

Healthcare administration costs $740 billion a year in the United States — and only $63 billion of that goes toward healthcare IT. That gap is closing fast. Menlo Ventures reports healthcare AI spending hit $1.4 billion in 2025, nearly tripling 2024's $500 million. The industry that once trailed every major technology wave is now deploying AI at 2.2x the rate of the broader economy.

This isn't a story about enthusiasm or experimentation. It's about margin pressure, staff shortages, and administrative overhead finally reaching the tipping point where doing nothing costs more than changing.

RCM Investment: Where Healthcare Tech Dollars Are Going

The $1.4 billion in healthcare AI spending isn't distributed evenly. Two categories dominate: ambient clinical documentation ($600 million, growing 2.4x year-over-year) and coding and billing automation ($450 million). Together, they represent roughly 75% of all healthcare AI investment.

The concentration isn't accidental. These are the two areas where AI delivers measurable ROI without requiring a fundamental redesign of clinical workflows. Documentation reduces physician burnout and captures charges that would otherwise be missed. Coding automation improves clean claim rates, reduces denials, and cuts the rework that drains A/R team capacity.

Everything else — prior authorization, patient engagement, utilization management — is secondary in terms of current spend, though not in terms of strategic importance.

RCM Is the Top Investment Priority for Providers

Nearly half of healthcare providers — 49%, per KLAS Research and Bain & Company — rank RCM among their top three technology investment priorities. The reason is structural: RCM improvements generate hard-dollar returns, not just efficiency gains that are difficult to quantify.

As KLAS/Bain put it: "RCM's appeal lies in hard‑dollar ROI: Accurate documentation and coding, resulting in cleaner claims and fewer denials, lead to measurable gains on both the revenue and expense lines."

Prior authorization, payment posting, eligibility verification, denial management — these are workflows where AI doesn't just assist a human. It replaces a step that previously required one. That distinction matters when you're trying to justify technology spend to a CFO who has already cut headcount twice in three years.

Healthcare Now Deploys AI Faster Than Any Other Industry

Twenty-two percent of healthcare organizations have implemented domain-specific AI tools, a 7x increase over 2024 and 10x over 2023, according to Menlo Ventures. Health systems lead at 27% adoption; outpatient providers sit at 18%; payers trail at 14%.

Fewer than one in ten companies across the broader economy (9%) has implemented AI at a comparable level. Most rely on general-purpose tools like enterprise ChatGPT rather than purpose-built clinical or financial applications.

The top AI use cases in provider settings, per KLAS/Bain, are:

• Documentation support, including ambient listening: 62%
• Clinical documentation improvement (CDI): 43%
• Medical coding: 30%
• Prior authorization: 27%

What these applications share: high volume, significant staff burden, and a clear connection to revenue or cost. Organizations aren't deploying AI where it's interesting — they're deploying it where it pays.

Buying Cycles: Providers Move Fast, Payers Slow Down

The procurement data reveals a meaningful split between payers and providers.

Health systems have cut their average AI buying cycle from 8.0 months (for traditional IT) to 6.6 months — a 17.5% reduction. Outpatient providers have moved even faster, dropping from 6.0 months to 4.7 months, a 22% reduction. These are organizations treating AI acquisition as a clinical and operational imperative, not a procurement exercise.

Payers have done the opposite. Their average buying cycle has lengthened from 9.4 months to 11.3 months — a 20% increase — per Menlo Ventures. The National Association of Insurance Commissioners found that 84% of insurers use AI in some form, but use cases skew toward fraud detection (50%), prior authorization (68%), and disease management (61%). These are applications that benefit payers operationally — and some of which create friction for providers.

The divergence reflects different pressures. Providers face margin erosion and staffing shortages that AI can directly address. Payers are navigating higher medical loss ratios and enrollment uncertainty, which produces more caution, not less. The practical consequence: providers who move quickly on AI gain durable operational advantages while payers catch up.

Startups Capture 85% of Healthcare AI Spend

Eighty-five percent of generative AI spending in healthcare flows to startups rather than to legacy healthcare IT vendors. Healthcare AI has produced eight unicorns — more than any other vertical AI segment, including legal, financial services, and media — and several companies valued between $500 million and $1 billion.

The explanation is straightforward. AI-native companies design products around AI capabilities from day one, without the technical debt or organizational drag of large incumbents. The advantage compounds: startups ship faster, iterate closer to customer feedback, and aren't constrained by EHR interoperability politics.

As Menlo Ventures noted: "The larger and more transformative opportunity lies in automating manual workflows that were never part of IT budgets, effectively converting services dollars into software dollars for the first time."

This shift from services-funded to software-funded workflows is the defining structural change in RCM technology. Prior authorization work done by staff is a services expense. Prior authorization automation is a software expense — and the unit economics are fundamentally different.

Five Strategies for Getting the ROI Right

AI is a massive opportunity for RCM. It is also easy to implement poorly. Here's where organizations that are capturing durable value differ from those still running pilots.

1. Focus Upstream — Denial Prevention, Not Denial Appeals

Appealing rejected claims is expensive. The cost per appeal, the time it consumes, and the revenue that never fully recovers adds up fast. Leading organizations are investing upstream: in ambient documentation that creates accurate clinical records at the point of care, and in real-time eligibility verification that surfaces coverage gaps and authorization requirements before services are rendered.

The upstream focus has compounding benefits. Better documentation improves coding accuracy. Better coding reduces denials. Fewer denials reduce A/R cycle length. Each step reinforces the next.

2. Convert Services to Software

Of the $740 billion spent on U.S. healthcare administration annually, only $63 billion goes to healthcare IT. The remainder funds people performing tasks that AI can now automate.

Prior authorization is the clearest example. Physicians and their staff spend an average of 13 hours per week on prior authorization requests — time that generates zero clinical value and substantial burnout. Automation tools cut that work from hours to minutes. Patient billing inquiries, care navigation, appointment scheduling, and front-office support follow the same pattern. The question isn't whether these workflows can be automated. It's whether your organization is capturing the conversion.

3. Build End-to-End Workflows, Not Point Solutions

A stack of disconnected AI tools creates integration overhead, vendor management complexity, and data inconsistencies that erode the efficiency gains each tool was supposed to deliver. The most effective AI implementations are embedded in end-to-end workflows with bidirectional EHR integration — meaning data flows without manual intervention in both directions, keeping systems current without human reconciliation.

When evaluating AI solutions, four questions cut through the noise:

• Does it reduce administrative burden on clinical staff?
• Does it improve the patient financial experience — clearer billing, easier payment, fewer surprises?
• Does it include human oversight for consequential decisions?
• Can it demonstrate ROI within six months?

Solutions that can't answer all four clearly are point solutions dressed up as platforms.

4. Deploy AI for the Right Workflows First

Not every workflow benefits equally from automation. AI delivers the clearest value in high-volume, rules-based tasks that consume significant staff time but don't require clinical judgment: eligibility verification, payment posting, basic patient inquiries, and routine prior authorization submissions.

These are also the workflows where success is easiest to measure — days in A/R, first-pass resolution rate, clean claim rate, staff hours per transaction. Start where you can quantify the outcome. The metrics you use to justify the initial investment will also tell you where to expand.

5. Govern Before You Scale

AI systems can amplify biases present in training data, make high-stakes decisions without transparent logic, and create compliance exposure when not properly documented. The organizations scaling AI responsibly are building governance before they hit the edge cases, not after.

That means cross-functional governance committees with clinical, operational, financial, legal, and IT representation. It means documented audit trails for AI-influenced decisions. It means regular testing for demographic disparities and accuracy drift. And it means maintaining human review for claim denials, high-dollar authorizations, and fraud-related determinations — not because AI can't handle them, but because the accountability for those decisions cannot sit with a model.

What the Investment Data Actually Tells You

The $1.4 billion flowing into healthcare AI in 2025 isn't speculative. It reflects what providers have already concluded: the administrative status quo is untenable, and incremental staffing is not a solution. The organizations capturing this shift are those treating AI as an execution layer — not a feature to evaluate, but a core component of how revenue gets collected.

ENTER is built for exactly that. The platform automates eligibility verification, claim submission, payment posting, denial management, and contract lifecycle management across your existing EHR environment — without the integration friction or vendor complexity that slows most deployments down. See what that looks like for your organization at enter.health.

FAQ

Q: What is driving increased AI investment in healthcare RCM in 2025?

‍A: Healthcare organizations are contending with margin compression, persistent staffing shortages, and administrative costs that exceed $740 billion annually. AI in RCM delivers measurable financial returns through improved clean claim rates, reduced denial rates, and automation of high-volume manual workflows — outcomes that are directly quantifiable on both the revenue and expense lines.

Q: Which AI applications are seeing the highest adoption in provider organizations?

‍A: Per KLAS Research and Bain & Company, documentation support including ambient listening leads at 62% adoption, followed by clinical documentation improvement at 43%, medical coding at 30%, and prior authorization at 27%. These applications share a common profile: high transaction volume, significant staff burden, and clear ROI.

Q: Why are health systems shortening their AI buying cycles?

‍A: Health systems reduced their average AI procurement timeline from 8.0 months to 6.6 months — a 17.5% reduction — because administrative pressure has made speed a competitive advantage. Outpatient providers moved even faster, cutting timelines from 6.0 to 4.7 months. Unlike legacy IT purchases, AI tools can demonstrate ROI within weeks, compressing the justification process.

Q: How does the services-to-software shift affect RCM budgeting?

‍A: Most RCM operations — prior authorization, patient billing support, front-office intake — are funded through services budgets as labor expenses. AI automation converts those workflows into software expenses, which typically carry lower per-unit costs and don't scale linearly with volume. This is why Menlo Ventures describes the opportunity as "converting services dollars into software dollars for the first time."

Q: What governance structures should healthcare organizations put in place before scaling AI?

‍A: Effective AI governance includes cross-functional oversight committees, documented decision logic and audit trails, regular testing for accuracy and demographic bias, and defined thresholds for mandatory human review. Consequential decisions — claim denials, high-dollar authorizations, fraud-related determinations — should retain human accountability even when AI informs the recommendation.